Raskind_2000_Neurology_54_2261

Reference

Title : Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group - Raskind_2000_Neurology_54_2261
Author(s) : Raskind MA , Peskind ER , Wessel T , Yuan W
Ref : Neurology , 54 :2261 , 2000
Abstract : Raskind_2000_Neurology_54_2261
ESTHER : Raskind_2000_Neurology_54_2261
PubMedSearch : Raskind_2000_Neurology_54_2261
PubMedID: 10881250

Related information

Citations formats

Raskind MA, Peskind ER, Wessel T, Yuan W (2000)
Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group
Neurology 54 :2261

Raskind MA, Peskind ER, Wessel T, Yuan W (2000)
Neurology 54 :2261